Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Limiting Acetaminophen in Opioids Led to Less Liver Failure and Toxicity Injuries, Researchers Find A decade after the FDA limited the amount of acetaminophen used in opioid drugs, researchers found significant reductions in rates of liver toxicity linked to their use. March 13, 2023 Russell Maas Add Your Comments The findings of a new study suggest using lower doses of acetaminophen in prescription opioid medications has significantly reduced hospitalization rates for liver failure and toxicity injuries associated with the active ingredient in Tylenol. In a study published in the Journal of American Medical Association (JAMA) on March 7, researchers determined that a 2014 federal mandate preventing opioid medications from containing more than 325mg of acetaminophen has likely led to fewer liver injuries, which is a known risk associated with side effects of Tylenol and other over-the-counter pain medications. In 2014, the U.S. Food and Drug Administration enacted a rule that places a limit on the amount of acetaminophen used in prescription drugs that combined both opioids and acetaminophen, such as Percocet. The mandate was prompted by research which identified that nearly half of all hospitalizations for acute liver failure involved individuals using prescription drugs combining opioids and high doses of acetaminophen. In this new study, researchers from the University of Alabama and Weill Cornell Medicine reviewed data from the National Inpatient Sample (NIS) and the Acute Liver Failure Study Group (ALFSG), which collectively involved over 473 million hospitalization records from 1998 to 2019, focusing on those reporting acute liver failure. Researchers found that between 1998 and 2019, more than 41,000 individuals using opioid-acetaminophen combination prescriptions were hospitalized for acetaminophen and opioid toxicity resulting in liver failure or liver toxicity leading to potentially severe health consequences. The authors used a calculation to compare liver failure rates among prescription users before and after the FDA capped acetaminophen in opioid drugs at 325mg. The researchers found an average of 12.2 hospitalizations for acetaminophen liver failure prior to the 2014 mandate. After it went into effect, the average dropped to 4.4 cases per 100,000 hospitalizations. Not only did the overall rates of liver toxicity hospitalizations drop, but the number of incidents per year also decreased. Researchers found the odds of hospitalizations with acetaminophen and opioid toxicity increased 11% per year prior to the announcement, whereas they decreased 11% per year after the announcement. “The FDA mandate to limit acetaminophen to 325 mg/tablet in prescription combination acetaminophen and opioid medications was associated with a decline in hospitalizations involving acetaminophen and opioid toxicity,” the researchers concluded. Acetaminophen Side Effects and Risks Although Tylenol and over-the-counter pain medications containing acetaminophen are generally considered safe, there has been increasing evidence about a number of potential side effects that users may face, many of which have not been disclosed to users or the medical community in prior decades. In addition to questions about liver toxicity injuries that emerged about a decade ago, there has been increasing concerns in recent years about the pregnancy risks with Tylenol, following the publication of studies that have found pregnant women using acetaminophen for pain may face a greater risk of giving birth to a child diagnosed with autism or ADHD. As a result of the drug makers’ failure to warn about these pregnancy-related risks, Johnson & Johnson and other drug makers now face over one hundred Tylenol autism and ADHD lawsuits brought by families nationwide. Tylenol Autism Lawsuit Does your child have Austism from Tylenol Exposure? Learn More SEE IF YOU QUALIFY FOR COMPENSATION Tylenol Autism Lawsuit Does your child have Austism from Tylenol Exposure? Learn More SEE IF YOU QUALIFY FOR COMPENSATION In addition to the risk of autism, ADHD and other developmental problems from Tylenol, a recent study published in the Journal of Clinical Medicine last month found that children born to pregnant women who used acetaminophen were over 30% more likely to later develop asthma or wheezing. According to their findings, maternal exposure to acetaminophen was linked with a 34% increased risk of asthma occurring in their offspring, and a 31% increased risk of wheezing. In September 2021, researchers warned that doctors should reconsider the safety of Tylenol in pregnancy, after reviewing a series of studies which linked acetaminophen to problems for the developing baby. Written by: Russell Maas Managing Editor & Senior Legal Journalist Russell Maas is a paralegal and the Managing Editor of AboutLawsuits.com, where he has reported on mass tort litigation, medical recalls, and consumer safety issues since 2010. He brings legal experience from one of the nation’s leading personal injury law firms and oversees the site’s editorial strategy, including SEO and content development. Tags: Acetaminophen, ADHD, Autism, Liver Damage, Liver Injury, Liver Toxicity, Opioids, Percocet, Pregnancy, Tylenol More Tylenol Lawsuit Stories Appeals Court Urged To Reinstate Tylenol Lawsuits Over Autism, ADHD Risks September 29, 2025 Tylenol Autism Lawsuits May Get New Life After HHS Pregnancy Warnings September 23, 2025 Study Finds Autism, ADHD Risks Linked to Prenatal Acetaminophen Use August 25, 2025 0 Comments LinkedInThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Dupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (Posted: yesterday) Dupixent users are coming forward with accounts of devastating cancer diagnoses, saying the popular eczema drug masked early warning signs of cutaneous T-cell lymphoma. As the FDA investigates and the first lawsuit is filed, researchers warn Dupixent may unmask or accelerate hidden cancers, raising urgent questions about its long-term safety. MORE ABOUT: DUPIXENT LAWSUITDupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (09/15/2025)Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (09/04/2025) Lawsuits Over Vision Loss From Ozempic, Mounjaro Should Be Sent to New MDL Judge, Plaintiffs Argue (Posted: 2 days ago) Plaintiffs involved in GLP-1 vision loss lawsuits are calling for the litigation to be consolidated in New Jersey federal court, and not be bundled with existing stomach paralysis litigation. MORE ABOUT: OZEMPIC LAWSUITReports of ‘Ozempic Teeth’ Raise Concerns Over Dry Mouth Side Effects Linked to GLP-1s (10/03/2025)Study Raises New Questions Over Ozempic Hair Loss Risks (09/26/2025)Mounjaro Side Effects Led to Emergency Surgery, Lawsuit Alleges (09/24/2025) Over 1,300 Depo Shot Lawsuits Now Being Pursued by Women With Meningioma Tumors (Posted: 3 days ago) A federal judge has called for more coordination between state and federal courts handling Depo shot lawsuits claiming the contraceptive causes brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Brain Tumor Lawsuit Describes Left-Sided Numbness, Tingling Before Diagnosis (10/01/2025)Judge To Hear Depo-Provera Lawsuit Preemption Arguments on Monday (09/26/2025)Link Between Depo-Provera and Meningioma Brain Tumors Ignored by Pfizer, Plaintiffs Indicate (09/22/2025)
Dupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (Posted: yesterday) Dupixent users are coming forward with accounts of devastating cancer diagnoses, saying the popular eczema drug masked early warning signs of cutaneous T-cell lymphoma. As the FDA investigates and the first lawsuit is filed, researchers warn Dupixent may unmask or accelerate hidden cancers, raising urgent questions about its long-term safety. MORE ABOUT: DUPIXENT LAWSUITDupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (09/15/2025)Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (09/04/2025)
Lawsuits Over Vision Loss From Ozempic, Mounjaro Should Be Sent to New MDL Judge, Plaintiffs Argue (Posted: 2 days ago) Plaintiffs involved in GLP-1 vision loss lawsuits are calling for the litigation to be consolidated in New Jersey federal court, and not be bundled with existing stomach paralysis litigation. MORE ABOUT: OZEMPIC LAWSUITReports of ‘Ozempic Teeth’ Raise Concerns Over Dry Mouth Side Effects Linked to GLP-1s (10/03/2025)Study Raises New Questions Over Ozempic Hair Loss Risks (09/26/2025)Mounjaro Side Effects Led to Emergency Surgery, Lawsuit Alleges (09/24/2025)
Over 1,300 Depo Shot Lawsuits Now Being Pursued by Women With Meningioma Tumors (Posted: 3 days ago) A federal judge has called for more coordination between state and federal courts handling Depo shot lawsuits claiming the contraceptive causes brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Brain Tumor Lawsuit Describes Left-Sided Numbness, Tingling Before Diagnosis (10/01/2025)Judge To Hear Depo-Provera Lawsuit Preemption Arguments on Monday (09/26/2025)Link Between Depo-Provera and Meningioma Brain Tumors Ignored by Pfizer, Plaintiffs Indicate (09/22/2025)